Slovenia's pharmaceutical market is one of the most developed in Central and Eastern Europe according to market intelligence company Business Monitor International. This is due to the well-established tradition of pharmaceuticals manufacturing in the country and its tight relations with European Union (EU). Slovenian pharmaceutical market size was EUR 738 mln in 2012, of which generic medicines accounted for 32.5%.
In 2012 Slovenia’s drug companies Krka d.d. and Lek d.d. registered the highest total revenue out of the 20 biggest pharmaceutical manufacturers in SEE region in terms of total revenue and they captured a 52% market share.